Stimulant Laxative — Constipation in Children
Pregnancy: Avoid in first trimester; short courses acceptable in later pregnancy for constipation unresponsive to dietary measures and osmotic laxatives
Senna (Paediatric)
Brand names: Senokot, Ex-Lax
Adult dose
Dose: 2–4 tablets (15–30 mg sennosides) at bedtime
Route: Oral
Frequency: Once daily at bedtime
Max: 4 tablets/day
Adult reference — see paediatric dose section
Paediatric dose
Route: Oral (syrup 7.5 mg/5 mL)
Frequency: Once daily at bedtime (bowel motion expected 8–12 hours later)
Max: Age-banded
BNFc: 1 month–4 years: 2.5–10 mL syrup at night; 4–18 years: 2.5–20 mL syrup at night (adjust to response). Do not use for more than 5 days without medical review (acute constipation) — longer courses acceptable under medical supervision for chronic constipation. Not suitable for bowel obstruction. Onset 8–12 hours — give at bedtime for morning action. Often combined with softener (lactulose) in stepwise approach.
Dose adjustments
Renal
No dose adjustment required
Hepatic
No dose adjustment required
Clinical pearls
- Stimulant vs osmotic laxatives: senna stimulates colonic peristalsis (anthraquinone glycoside → active anthrones irritate myenteric plexus); macrogol/lactulose work osmotically — different mechanisms, different onset (senna: 8–12 hours; osmotic: 12–48 hours)
- NICE NG90: disimpaction first (macrogol high-dose), then maintenance; senna added as step-up if macrogol alone insufficient — combined osmotic + stimulant approach
- Senna should be avoided long-term without monitoring — stimulant laxatives can cause hyponatraemia, hypokalaemia; monitor electrolytes if used beyond 2–4 weeks
- Melanosis coli: long-term senna use causes reversible brown/black pigmentation of colonic mucosa (lipofuscin deposition in macrophages) — seen on colonoscopy; does not indicate pathology; reassure and reduce dose
Contraindications
- Intestinal obstruction
- Ileus
- Dehydration with electrolyte disturbance
- Inflammatory bowel disease (acute attack)
- Children under 1 month
Side effects
- Abdominal cramps (very common)
- Diarrhoea (excess doses)
- Electrolyte disturbance (prolonged high-dose use)
- Melanosis coli (long-term use — reversible brown pigmentation of colonic mucosa)
- Dependency (chronic overuse)
Interactions
- Antiarrhythmics — electrolyte disturbance from laxative abuse may worsen arrhythmia
- Cardiac glycosides (digoxin) — hypokalaemia from laxative overuse increases digoxin toxicity
Monitoring
- Stool frequency and consistency (Bristol Stool Scale)
- Electrolytes (sodium, potassium — prolonged use)
- Abdominal examination (obstruction signs)
- Dietary and fluid intake assessment
Reference: BNF for Children; NICE NG90 (Constipation in Children); ESPGHAN Childhood Constipation Guidelines 2014. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- PICU Delirium Assessment (pCAM-ICU) · Delirium Assessment
- Vasoactive-Inotropic Score (VIS) · Inotropic Support
- Lund-Browder Chart — TBSA Burn Estimation · Burns
- Bristol Stool Form Scale · GI Assessment
- Rome IV Diagnostic Criteria for Functional Constipation · Functional GI Disorders
- Kocher Criteria for Septic Arthritis · Bone & Joint Infection